Preoperative exclusive enteral nutrition ameliorates CRP-to-albumin ratio without affecting body mass index in Crohn’s disease

Authors:

Abstract
Background: Crohn’s disease (CD) frequently exhibits malnutrition and systemic inflammation, both of which are closely linked to elevated surgical risks and postoperative complications. Exclusive enteral nutrition (EEN) is a standard nutritional therapy for CD, yet whether its core mechanism functions via nutritional support to improve body mass index (BMI) or via nutritional treatment to modulate inflammation, altering the C-reactive protein-to-albumin ratio (CAR) remains inadequately understood. Besides its related alterations in computed tomography enterography (CTE) parameters and laparoscopic surgery outcomes also remain important points. Methods: A cohort study was conducted at our Inflammatory Bowel Disease Center, enrolling 89 CD patients undergoing bowel resection. Those patients received EEN for 6 weeks preoperatively. All data were collected from a database. Moreover, cross-sectional imaging metrics were assessed by CTE parameters to further demonstrate the impact brought by EEN. Postoperative complications within 30 days were also recorded. Results: Preoperative EEN treatment significantly increased albumin levels (from 34.4 ± 4.1 g/L at baseline to 38.9 ± 4.5 g/L before surgery, p < 0.001), as well as improving inflammatory status via reduced CRP levels [from 23.0 (10.1, 36.5) mg/L at baseline to 2.8 (1.2, 5.0) mg/L before surgery, p < 0.001] and consequently decreased CAR (from 0.83 ± 0.79 g/L at baseline to 0.28 ± 0.75 g/L before surgery, p < 0.001). Patients receiving EEN also experienced fewer postoperative complications and a shorter postoperative length of stay. However, it was worth noting that BMI remained relative unchanged after EEN therapy (from 19.2 ± 3.4 kg/m 2 at baseline to 19.3 ± 3.1 kg/m 2 before surgery, p = 0.821). Conclusion: Preoperative EEN in CD patients effectively ameliorates the CAR without prominently affecting BMI. As a targeted anti-inflammatory strategy in the immediate preoperative period, EEN exerts its benefits primarily through rapid modulation of inflammation rather than weight gain.

This publication has 40 references indexed in Scilit: